Jae Hoon Park

Title: Innovations of Jae Hoon Park in Pharmaceutical Composition

Introduction

Jae Hoon Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating osteoporosis and related conditions. With a total of 4 patents, his work has garnered attention in the scientific community.

Latest Patents

Jae Hoon Park's latest patents include innovative formulations such as N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 ethansulfonic acid salt. This patent describes a process for the preparation of this compound and its pharmaceutical composition for preventing and treating osteoporosis, bone fractures, or allergic inflammatory diseases. Another significant patent involves a method of treating or preventing osteoporosis by administering an effective amount of a pharmaceutical composition comprising benzamidine derivatives or their salts, along with alendronic acid or its salt. The combination treatment exhibits an excellent inhibitory effect on osteoclast differentiation, making it a promising option for osteoporosis management.

Career Highlights

Throughout his career, Jae Hoon Park has worked with reputable companies such as Dong Wha Pharmaceutical Co. Ltd. and Dong Wha Pharmaceutical Ind. Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Jae Hoon Park has collaborated with notable colleagues, including Jin Soo Lee and Jei Man Ryu. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Jae Hoon Park's contributions to pharmaceutical compositions, particularly in the treatment of osteoporosis, highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical science and providing effective solutions for patients in need.